Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.

Add item related to this paper

  • MiniManuscript ID
    63334
  • Pubmed ID
    16199422